EUVIMEDEUVIMED entdecken
Übersichtsarbeit

UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes

Kevin R Nash, Umesh K Jinwal, Krishna Moorthi Bhat iD

Journal of Alzheimer’s Disease · 2024-11 · 102 (1) · 3-10

DOI: 10.1177/13872877241283680 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 17.10.2024. Verfasst von Kevin R Nash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology and Physiology, College of Medicine, University of South Florida, Tampa, FL, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Neurodegenerative Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-translational modifications (PTMs) of proteins play a significant role in normal protein function but can also be instrumental in disease pathogenesis. One critical yet under-studied PTM in disease is ubiquitination. Ubiquitin chain addition and substrate specificity are determined by a large spectrum of ubiquitin-ligating and -modifying enzymes, E3 ligases, whose expression levels and activities are tightly regulated in a cell-specific manner. While most ubiquitin chains can target proteins for proteasomal degradation, ubiquitination can contribute to other functions within the cell, including protein localization, protein activity, endocytosis, transcription, and autophagy. One E3 ligase, UBE3A, has garnered much attention because of its involvement in learning and memory, as well as its association with neurodevelopmental autism spectrum disorders (ASDs). However, more recent findings have suggested a potential involvement of UBE3A in neurodegenerative proteinopathies, where reduced UBE3A levels can lead to an enhanced rate of aggregate formation and cell death. Here, we review the literature on UBE3A in neurodevelopment, function, and neurodegenerative diseases and demonstrate that UBE3A could play a critical role in disease progression and cognitive function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesNeurodegenerative DiseasesHumansAnimalsUbiquitinationNeurodevelopmental Disorders

Stichwörter der Autor:innen

Alzheimer's diseaseAngelman syndromeHuntington's diseaseUBE3Aneurodegenerative diseaseneurodevelopmentubiquitination

Substanzen

Ubiquitin-Protein LigasesUBE3A protein, human

Autor:innen und Institutionen

  • Department of Molecular Pharmacology and Physiology, College of Medicine, University of South Florida, Tampa, FL, USA.
  • Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA.
  • Department of Biomedical Engineering and Department of Neurology, Heersink School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.

ORCID-Profile: Krishna Moorthi Bhat

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Nash, K. R., Jinwal, U. K., & Bhat, K. M. (2024). UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes. Journal of Alzheimer’s Disease, 102(1), 3-10. https://doi.org/10.1177/13872877241283680

Vancouver

Nash KR, Jinwal UK, Bhat KM. UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes. Journal of Alzheimer’s Disease. 2024;102(1):3-10. doi:10.1177/13872877241283680

BibTeX
@article{Nash2024,
  author = {Nash, Kevin R and Jinwal, Umesh K and Bhat, Krishna Moorthi},
  title = {UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  volume = {102},
  number = {1},
  pages = {3--10},
  doi = {10.1177/13872877241283680}
}
Kostenlos starten →